Research and Markets
(http://www.researchandmarkets.com/research/tk4t8w/2015_strategies)
has announced the addition of the "2015 Strategies in the Global
Clinical Chemistry and Immunodiagnostics Market" report to their
offering.
"2015 Strategies in the Global Clinical Chemistry and
Immunodiagnostics Market" is a new seven-country strategic analysis
of major business opportunities emerging in the clinical chemistry
and immunodiagnostic markets during the next five years. The report
explores future trends in the U.S., five major European countries
(France, Germany, Italy, Spain, UK) and Japan; provides estimates
of the specimen, test and sales volumes, as well as major
suppliers' sales and market shares; compares features of leading
analyzers; profiles key competitors; and identifies specific
product and marketing opportunities emerging during the next five
years.
The report provides five-year volume and sales forecasts for
over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein
and abused drug assays performed in hospitals, commercial
laboratories, physician offices, and ambulatory care centers,
including controls, calibrators and consumables.
Rationale
The clinical chemistry and immunodiagnostic markets are
undergoing significant transformation, caused by convergence of new
and more stringent regulations; advances in diagnostic
technologies, system engineering, automation, and IT; and
intensifying competition. Some segments, like routine chemistry,
are already resembling commodity markets, where product positioning
and cost per test are more critical than underlying technology.
This evolving marketplace creates exciting opportunities for a
variety of new instruments, reagent systems, and auxiliary
products, such as specimen preparation devices, controls, and
calibrators.
Worldwide Market Overview
- Estimates of facilities performing clinical chemistry and
immunodiagnostic tests by country.
- Test volume and sales projections by country.
Strategic Recommendations
- New product development opportunities with significant market
appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Competitive Assessments
- Strategic assessments of major suppliers and emerging market
entrants, including their sales, product portfolios, marketing
tactics, collaborative arrangements and new products in
R&D.
- The companies analyzed in the report include Abbott, AdnaGen,
Agilent, Alere, Beckman Coulter/Danaher, Biomedical Diagnostics,
bioMerieux, Bio-Rad, DiaSorin, Eiken, Fujirebio/Innogenetics, IL,
Kyowa Medex, Ortho-Clinical Diagnostics, Roche, Siemens, Sysmex,
Thermo Fisher, Tosoh, Wako, Wallac/PE.
Tests Analyzed in the Report:
Routine Clinical Chemistry
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase,
AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium,
Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol,
Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT,
Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol,
Magnesium, Phosphorus, Potassium, Protein, Total, Sodium,
Triglycerides, Troponin, Uric Acid.
Therapeutic Drug Monitoring (TDM)
Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus,
Gentamicin, Levetiracetam, Lithium, Methotrexate,
NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus,
Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid,
Vancomycin.
Endocrine Function
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO
PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG,
Testosterone, Thyroglobulin Ab, TPO Ab, TSH.
Tumor Markers and Special Chemistry
AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic
Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3,
Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.
Immunoproteins
C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE
Total, IgG, IgM, Immunofixation, Prealbumin, Protein
Electrophoresis.
Drugs of Abuse
Amphetamines, Barbiturates, Benzodiazepines,
Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone,
Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic
Antidepressants.
Market Segmentation Analysis
- Comprehensive review of the market dynamics, trends,
structure, size, growth, and key suppliers, by country.
Test volume and sales forecasts for over 100 clinical chemistry,
TDM, endocrine, cancer, immunoprotein and abused drug assays, by
country and market segment:
- Hospitals
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Ambulatory Care Centers
Current and Emerging Products
- Analysis of current and emerging clinical chemistry and
immunodiagnostic tests.
- Review of current instrumentation technologies, and feature
comparison of high, medium and low-volume/POC analyzers.
Technology Review
- Assessment of current and emerging technologies, and their
potentialmarket applications.
- Comprehensive lists of companies developing or marketing new
technologies and products by test.
For more information visit
http://www.researchandmarkets.com/research/tk4t8w/2015_strategies
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150728005805/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: In Vitro Diagnostics